{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:59:15Z","timestamp":1790816355214,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005337","name":"American Academy of Child and Adolescent Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Irving Institute","award":["UL1TR001873"],"award-info":[{"award-number":["UL1TR001873"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.schres.2018.10.017","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T00:10:29Z","timestamp":1541635829000},"page":"440-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Inflammatory biomarkers in psychosis and clinical high risk populations"],"prefix":"10.1016","volume":"206","author":[{"given":"Shannon","family":"Delaney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Alaedini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Indart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Javitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.10.017_bb0005","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/infdis\/jiu235","article-title":"Vitamin D deficiency promotes epithelial barrier dysfunction and intestinal inflammation","volume":"210","author":"Assa","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.schres.2018.10.017_bb0010","first-page":"263","article-title":"Endogenous endotoxin-core antibody (EndoCAb) as a marker of endotoxin exposure and a prognostic indicator: a review","volume":"392","author":"Barclay","year":"1995","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.schres.2018.10.017_bb0015","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.schres.2018.10.017_bb0020","doi-asserted-by":"crossref","first-page":"25502","DOI":"10.3390\/ijms161025502","article-title":"The Fab fragment of a humanized anti-toll like receptor 4 (TLR4) monoclonal antibody reduces the lipopolysaccharide response via TLR4 in mouse macrophage","volume":"16","author":"Cai","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.schres.2018.10.017_bb0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.neubiorev.2016.02.013","article-title":"Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases","volume":"64","author":"Garcia Bueno","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.schres.2018.10.017_bb0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/eip.12122","article-title":"Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia","volume":"9","author":"Graham","year":"2015","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2018.10.017_bb0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.psyneuen.2014.08.016","article-title":"Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood","volume":"50","author":"Grudet","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2018.10.017_bb0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/0148607104028006410","article-title":"Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity","volume":"28","author":"Khaodhiar","year":"2004","journal-title":"JPEN J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.schres.2018.10.017_bb0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ebiom.2017.11.027","article-title":"Vitamin D supplementation in chronic schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled clinical trial","volume":"26","author":"Krivoy","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.schres.2018.10.017_bb0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3389\/fimmu.2013.00189","article-title":"Vitamin-mediated regulation of intestinal immunity","volume":"4","author":"Kunisawa","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.schres.2018.10.017_bb0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MIB.0000000000000588","article-title":"Role of vitamin D in infliximab-induced remission in adult patients with Crohn's disease","volume":"22","author":"Reich","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.schres.2018.10.017_bb0060","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trsl.2016.10.002","article-title":"Feeding the microbiota-gut-brain axis: diet, microbiome, and neuropsychiatry","volume":"179","author":"Sandhu","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.schres.2018.10.017_bb0065","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.schres.2013.05.018","article-title":"Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia","volume":"148","author":"Severance","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.10.017_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pscychresns.2015.06.006","article-title":"Serum vitamin D and hippocampal gray matter volume in schizophrenia","volume":"233","author":"Shivakumar","year":"2015","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.schres.2018.10.017_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/cap.2014.0110","article-title":"Vitamin D3 supplemental treatment for mania in youth with bipolar Spectrum disorders","volume":"25","author":"Sikoglu","year":"2015","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.10.017_bb0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"10.1016\/j.schres.2018.10.017_bb0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/YIC.0b013e3283628f98","article-title":"Open-label pilot study on vitamin D3 supplementation for antipsychotic-associated metabolic anomalies","volume":"28","author":"Thakurathi","year":"2013","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.10.017_bb0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.schres.2018.10.017_bb0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jaci.2011.02.025","article-title":"Bacterial components plus vitamin D: the ultimate solution to the asthma (autoimmune disease) epidemic?","volume":"127","author":"Weiss","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.schres.2018.10.017_bb0100","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","article-title":"Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1","volume":"188","author":"Zhang","year":"2012","journal-title":"J. Immunol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418306194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T10:44:04Z","timestamp":1565261044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418306194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":20,"alternative-id":["S0920996418306194"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.10.017","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory biomarkers in psychosis and clinical high risk populations","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}